$162.85-1.99 (-1.21%)
The Bank of New York Mellon Corporation provides a range of financial products and services in the United States and internationally.
The Bank of New York Mellon Corporation in the Financial Services sector is trading at $162.85 with a market capitalization of $110.8B. Wall Street consensus targets $167.79 (14 analysts), implying a +3.0% move over the next 12 months. The stock is currently near its 52-week high of $165.84, remaining 23.0% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | — | $5.34B↑ | $5.11B↑ | $5.00B↑ | $4.96B |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| Net Income | — | $1.63B↑ | $1.46B↑ | $1.45B↑ | $1.42B |
The Bank of New York Mellon Corporation provides a range of financial products and services in the United States and internationally. It operates through Securities Services, Market and Wealth Services, Investment and Wealth Management, and Other seg...

BNY Mellon has outperformed all other major bank stocks over the past five years.

Gabelli Investment Management Firm recently released its “Equity Income Fund” second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The Fund highlighted a strong rebound in U.S. equities, during the second quarter of 2026, with its Class I shares gaining 6.76%, compared with a 9.70% return for the Lipper Equity Income […]

TFC's NII growth is likely to remain positive in 2026, backed by loan and earning-asset growth, but loan spreads and deposit mix could limit momentum.

As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the custody bank industry, including BNY (NYSE:BNY) and its peers.

BNY's 35.4% YTD rally is backed by rising net interest income, stronger platform execution, global scale and positive earnings estimate revisions.
Academic risk and quality models computed from BNY's own filings and price history, not from analyst opinion.
Mixed: 5 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
Hidden Markov model fitted to two years of returns, separating bull, bear and sideways states by their own drift and volatility.
GARCH(1,1) 30-day annualised forecast, above the current 18.4% reading.
Fama-French 5-factor market beta. The five factors explain 31% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-09-08.